Found: 8
Select item for more details and to access through your institution.
Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis with Mildly Decreased and Normal Lung Function: A Real-Life Observational Study.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Effect of late preterm birth on lung clearance index and respiratory physiology in school‐age children.
- Published in:
- Pediatric Pulmonology, 2019, v. 54, n. 8, p. 1250, doi. 10.1002/ppul.24357
- By:
- Publication type:
- Article
'I sit to sleep'-Spirometry as a clue to diagnosis.
- Published in:
- Pediatric Pulmonology, 2016, v. 51, n. 4, p. E13, doi. 10.1002/ppul.23362
- By:
- Publication type:
- Article
Lung Clearance Index (LCI) in Patients with Bronchiolitis Obliterans: A Preliminary Report and Comparison to Cystic Fibrosis Patients.
- Published in:
- Lung, 2016, v. 194, n. 6, p. 1007, doi. 10.1007/s00408-016-9934-8
- By:
- Publication type:
- Article
Pneumonia in the presentation of Kawasaki disease: The syndrome or a sequence of two diseases?
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Optimizing CFTR modulator therapy management for cystic fibrosis through the ReX platform.
- Published in:
- Frontiers in Pediatrics, 2023, p. 1, doi. 10.3389/fped.2023.1300968
- By:
- Publication type:
- Article
Exhaled Breath Condensate and Respiratory Sequelae in Children Post-COVID-19.
- Published in:
- Respiration, 2023, v. 102, n. 7, p. 479, doi. 10.1159/000530971
- By:
- Publication type:
- Article
Real life evaluation of the multi-organ effects of Lumacaftor/Ivacaftor on F508del homozygous cystic fibrosis patients.
- Published in:
- BMC Pharmacology & Toxicology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s40360-022-00624-z
- By:
- Publication type:
- Article